(Q40523209)

21 September 2017

Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis (English)

1 reference

21 September 2017

1 reference

1 reference

Dario Roccatello

1

1 reference

21 September 2017

Simone Baldovino

2

1 reference

21 September 2017

Daniela Rossi

3

1 reference

21 September 2017

Morteza Mansouri

4

1 reference

21 September 2017

Carla Naretto

5

1 reference

21 September 2017

Mariella Gennaro

6

1 reference

21 September 2017

Roberto Cavallo

7

1 reference

21 September 2017

Mirella Alpa

8

1 reference

21 September 2017

Piera Costanzo

9

1 reference

21 September 2017

Osvaldo Giachino

10

1 reference

21 September 2017

Gianna Mazzucco

11

1 reference

21 September 2017

Luigi Massimino Sena

12

1 reference

21 September 2017

language of work or name

English

0 references

publication date

19 October 2004

1 reference

Nephrology Dialysis Transplantation

21 September 2017

1 reference

21 September 2017

19

1 reference

21 September 2017

3054-3061

1 reference

21 September 2017

12

1 reference

Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis

21 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH469

Mixed cryoglobulinemia: new concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH469

Role of monocytes in cryoglobulinemia-associated nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH469

Binding of hepatitis C virus to CD81

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH469

T(14;18) translocation in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH469

Efficacy and safety of rituximab in type II mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH469

Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH469

Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH469

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH469

Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH469

Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH469

Treating human autoimmune disease by depleting B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH469

Impaired hepatosplenic elimination of circulating cryoglobulins in patients with essential mixed cryoglobulinaemia and hepatitis C virus (HCV) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH469

21 January 2018

Identifiers

DOI

10.1093/NDT/GFH469

1 reference

21 September 2017

1 reference